Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis

BACKGROUND: Previous studies have reported that tafamidis treatment was associated with better outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) compared with those without tafamidis treatment. Therefore, we aimed to systematically assess the association of tafamidis treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jie, Chen, Hongyu, Tang, Zihuan, Zhang, Jinquan, Xu, Yuanwei, Wan, Ke, Hussain, Kifah, Gkoutos, Georgios V., Han, Yuchi, Chen, Yucheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474377/
https://www.ncbi.nlm.nih.gov/pubmed/37662524
http://dx.doi.org/10.1016/j.eclinm.2023.102172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474377/
https://www.ncbi.nlm.nih.gov/pubmed/37662524
http://dx.doi.org/10.1016/j.eclinm.2023.102172

Ejemplares similares